Mednax Inc (MD)

Based on the provided data for Mednax Inc's liquidity ratios:

1. Current Ratio:
- The company's current ratio has shown a decline from 3.66 in December 2020 to 1.47 in December 2024.
- A current ratio above 1 indicates that Mednax Inc had more current assets than current liabilities for all years, reflecting a healthy liquidity position. However, the decreasing trend indicates a potential concern in managing short-term obligations efficiently.

2. Quick Ratio:
- The quick ratio also exhibited a downward trend from 2.90 in December 2020 to 0.80 in December 2024.
- A quick ratio below 1 suggests that the company may struggle to meet its short-term obligations without relying on the sale of inventory. The declining trend highlights a potential risk in short-term liquidity management.

3. Cash Ratio:
- The cash ratio begins at 2.90 in December 2020 but then falls to 0.80 by December 2024.
- The cash ratio measures the ability of a company to cover its current liabilities with cash and cash equivalents. A ratio below 1 indicates that the company may have difficulty meeting its short-term obligations solely with its cash reserves. The decreasing trend in the cash ratio implies a declining ability to cover short-term liabilities with cash.

Overall, Mednax Inc's liquidity ratios have shown a declining trend over the years, which may suggest a potential strain in meeting short-term obligations without resorting to selling inventory or managing cash efficiently. This could pose liquidity challenges for the company if the trend continues, and may require closer monitoring and management of working capital to ensure financial stability.

---

Additional liquidity measure

Based on the data provided, Mednax Inc's cash conversion cycle has remained steady at 0.00 days from December 31, 2020, to December 31, 2021. This implies that the company efficiently converts its inventory into cash and collects receivables quickly, resulting in a short cash conversion cycle.

However, there was a slight deviation observed on December 31, 2023, where the cash conversion cycle increased to 3.14 days. This may suggest a temporary delay in converting inventory to sales or collecting receivables, impacting the company's liquidity and operational efficiency.

Overall, the company has historically demonstrated strong management of its working capital and cash flows, maintaining a generally low and stable cash conversion cycle. Monitoring and addressing any fluctuations in the future will be essential to ensure continued financial health and efficiency.